Swang Chai Chuan Limited (HKG:2321)

Theseus Pharmaceuticals Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	54.41	45.17	23.03	4.48	13.01
Short-Term Investments	25.86	15.24	45.31	-	-
Trading Asset Securities	-	-	-	0.23	5.95
Cash & Short-Term Investments	80.27	60.41	68.34	4.71	18.97
Cash Growth	32.88%	-11.61%	1350.01%	-75.15%	59.61%
Accounts Receivable	129.77	116.24	117.28	88.1	67.82
Other Receivables	11.31	7.4	5.21	-	0.4
Receivables	141.07	123.64	122.49	88.1	68.22
Inventory	83.86	87.94	97.9	56.29	45.03
Other Current Assets	24.1	11.69	20.52	20.36	27.66
Total Current Assets	329.3	283.67	309.25	169.47	159.88
Property, Plant & Equipment	60.82	62.81	57.27	41.78	38.31
Long-Term Investments	0.11	0.04	0.23	-	-
Long-Term Deferred Tax Assets	1.72	2.54	2.35	1.77	1.05
Other Long-Term Assets	-	-	-	-	1.82
Total Assets	391.94	349.06	369.1	213.02	201.06
Accounts Payable	69.43	52.34	60.46	37.11	30.76
Accrued Expenses	12.8	7.25	12.97	8.09	8.69
Short-Term Debt	-	-	-	2.54	4.66
Current Portion of Long-Term Debt	22.96	27.63	48.72	26.07	21.09
Current Portion of Leases	0.82	1.29	10.46	1.41	1.38
Current Income Taxes Payable	-	-	0.9	1.65	0.38
Current Unearned Revenue	6.45	5.69	5.98	7.03	4.42
Other Current Liabilities	-	0.19	0.27	1.11	23.03
Total Current Liabilities	112.46	94.38	139.76	85.02	94.4
Long-Term Debt	27.91	23.37	14.55	15.25	17.12
Long-Term Leases	2.02	2.62	0.77	1.98	2.43
Long-Term Deferred Tax Liabilities	1.29	1.17	1.09	0.59	0.53
Total Liabilities	143.69	121.54	156.17	102.84	114.48
Common Stock	5.71	5.71	5.71	-	-
Additional Paid-In Capital	71.06	71.06	71.06	-	-
Retained Earnings	170.26	150.34	136.92	110.14	86.55
Comprehensive Income & Other	1.23	0.43	-0.76	0.05	0.03
Shareholders' Equity	248.26	227.53	212.93	110.19	86.57
Total Liabilities & Equity	391.94	349.06	369.1	213.02	201.06
Total Debt	53.72	54.91	74.5	47.25	46.68
Net Cash (Debt)	26.55	5.5	-6.16	-42.53	-27.71
Net Cash Growth	383.04%	-	-	-	-
Net Cash Per Share	0.03	0.01	-0.01	-0.06	-
Filing Date Shares Outstanding	1,000	1,000	1,000	723	-
Total Common Shares Outstanding	1,000	1,000	1,000	723	-
Working Capital	216.83	189.29	169.49	84.45	65.48
Book Value Per Share	0.25	0.23	0.21	0.15	-
Tangible Book Value	248.26	227.53	212.93	110.19	86.57
Tangible Book Value Per Share	0.25	0.23	0.21	0.15	-
Land	15.08	15.52	15.52	10.52	9.06
Buildings	18.36	13.87	13.87	13.87	13.74
Machinery	46.25	45.51	32.52	28.15	25.76
Construction In Progress	1.39	-	-	-	-
Leasehold Improvements	1.48	1.48	1.48	0.81	0.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.